DigestRedComo funciona
Digest/ Comunicado

The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. today reviewed and approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2024.

FuenteFine Foods & Pharmaceuticals N.T.M. S.p.A
Editor 1INFO
Compatibilidad
Ahorrar(0)
Compartir
The Board of Directors of Fine Foods & Pharmaceuticals N.T.M. S.p.A. today reviewed and approved the Draft Financial Statements and Consolidated Financial Statements as of 31 December 2024.
Materiales adjuntos (1)

20094_151100_2025_oneinfo.pdf

Descargar kit de prensa ->
Detalles de contacto

Comunicados relacionados

14/11/2024
Finanzas
Ahorro/Finanzas personales
Fondos de inversión
Industria
THE BOARD OF DIRECTORS OF FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A. TODAY APPROVED THE GROUP'S INTERIM FINANCIAL REPORT AS OF 30 SEPTEMBER 2024. ADJUSTED EBITDA OF € 23.4 MILLION (+27.8%)
Fuente
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Editor
1INFO
Descubre afinidades
0
13/09/2024
Finanzas
Ahorro/Finanzas personales
Fondos de inversión
Industria
THE BOARD OF DIRECTORS OF FINE FOODS & PHARMACEUTICALS N.T.M. S.P.A APPROVED THE 30 JUNE 2024 HALF-YEAR FINANCIAL REPORT: RECORD FIRST-HALF EBITDA OF € 16 MILLION AND A STRONG PROFITABILITY INCREASE
Fuente
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Editor
1INFO
Descubre afinidades
0
28/02/2025
Finanzas
Ahorro/Finanzas personales
Fondos de inversión
Industria
Pietro Oriani confirmed as Chief Executive Officer - EY appointed to certify sustainability report compliance
Fuente
Fine Foods & Pharmaceuticals N.T.M. S.p.A
Editor
1INFO
Descubre afinidades
0